FDA PMA
FDA Class 3
Approved
🇺🇸 United States
Implanted Phrenic Nerve Stimulator For Central Sleep Apnea
PMA: P160039
·
Supplement: S006
·
Decision Jul 28, 2021
Classifications
1
FEI Numbers
3
Registration Numbers
3
Basic Information
- Device Name
- Implanted Phrenic Nerve Stimulator For Central Sleep Apnea
- Trade Name
- remede System
- PMA Number
- P160039
- Supplement Number
- S006
- Device Class
- FDA Class 3
- Product Code
- PSR
- Generic Name
- Implanted phrenic nerve stimulator for central sleep apnea
- Medical Specialty
- Unknown
- Advisory Committee
- Anesthesiology
- Decision
- Approved
- Decision Code
- APPR
- Decision Date
- July 28, 2021
- Date Received
- January 19, 2021
- Supplement Type
- Normal 180 Day Track
- Supplement Reason
- Change Design/Components/Specifications/Material
- Expedited Review
- N
Advisory Committee Statement
Approval for reducing the IPG size, increasing the IPG battery longevity, reducing the number of set screw connections between the lead terminal and IPG header, and improving features within the Remede Programer software application and the remede Reports application.
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| PSR | Implanted Phrenic Nerve Stimulator For Central Sleep Apnea | FDA class 3 | Unknown |